SCHEMBL16400757

SCHEMBL16400757

CC(C)(C)[Si](OC1CCN(C(=O)O)C(=O)C1)(c1ccccc1)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CHRM3 P20309 6/20 0.36
CHRM2 P08172 2/20 0.33
CHRM1 P11229 2/20 0.33
MLNR O43193 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HRH1 P35367 1/20 0.33
OPRM1 P35372 1/20 0.33
DRD3 P35462 1/20 0.33
OPRK1 P41145 1/20 0.33
HTR2B P41595 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33
CACNA1C Q13936 1/20 0.33
GPR119 Q8TDV5 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CHRM4 P08173 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16409414 0.90 GPR119 (0.40) MEN1KMT2ACHRM3GPR119
SCHEMBL516800 0.81 MEN1 (0.40) BACE1MEN1KMT2ACHRM3CHRM1
SCHEMBL16401254 0.81 BACE1 (0.36) BACE1MEN1KMT2ACHRM3
SCHEMBL26985459 0.80 MEN1 (0.41) MEN1KMT2AGPR119
SCHEMBL30065370 0.79 MEN1 (0.38) BACE1MEN1KMT2ACHRM3CHRM1
SCHEMBL5880292 0.77 BACE1 (0.39) BACE1
SCHEMBL15032343 0.77 GPR119 (0.55) MEN1KMT2AGPR119
SCHEMBL14945259 0.76 MEN1 (0.38) BACE1MEN1KMT2ACHRM3CHRM1
SCHEMBL31441735 0.76 BRD4 (0.44) BACE1KMT2A
SCHEMBL31441697 0.76 BRD4 (0.44) BACE1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3022192-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS Novartis AG (CH) 2016-05-25 EP disclosed
WO-2015009616-A1 PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS NOVARTIS AG (CH) 2015-01-22 WO disclosed